DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Reset all filters
01 3Dr. Reddy's Laboratories
02 2NanoAlvand
03 2Lee Fine Chem
04 3Accord healthcare
05 2Accure Labs
06 3Apotex Inc
07 2Azurity Pharma
08 7Bluepharma
09 3Cipla
10 1Health Biotech
11 5Hetero Drugs
12 3Intas Pharmaceuticals
13 2Jodas Expoim Pvt. Ltd
14 2MSN Laboratories
15 1Naprod Life Sciences
16 7Novartis Pharmaceuticals Australia Pty Limited
17 8Novartis Pharmaceuticals Corporation
18 2Novartis South Africa (Pty) Ltd
19 1Pharmacare Premium
20 3Pinnacle Life Science
21 2Pluviaendo
22 6STADA Arzneimittel
23 2Sichuan Xieli Pharmaceutical
24 5Teva Pharmaceutical Industries
25 2TherDose Pharma
26 2Torrent Pharmaceuticals Limited
27 2Zentiva
Reset all filters
01 4CAP
02 9CAPSULE
03 11CAPSULE;ORAL
04 21Capsule
05 6Capsules
06 17Hard Capsule
07 2Hard Gelatin Capsule
08 3Oral Solid Dosage Form
09 2TABLET;ORAL
10 8Blank
Reset all filters
01 9Approved
02 14Authorized
03 8Generic
04 3Lead Market Dossiers- Under Development
05 2Originator
06 11RX
07 36Blank
Reset all filters
01 2Assignment
02 2DANZITEN
03 2Lotigna
04 4NILOTINIB
05 3NILOTINIB D-TARTRATE
06 3NILOTINIB HYDROCHLORIDE
07 3NILOTINIB HYDROCHLORIDE DIHYDRATE
08 5Nilotinib
09 3Nilotinib Accord
10 6Nilotinib Stada
11 5Nilotinib Teva
12 4Sunitinib Bluepharma Industry
13 3TASIGNA
14 1Tasicap 150
15 1Tasicap 200
16 10Tasigna
17 1Tasigna 150 Mg
18 1Tasigna 200 Mg
19 24Blank
Reset all filters
01 7Australia
02 2China
03 2Czech Republic
04 19India
05 2Iran
06 1Malta
07 3Portugal
08 4South Africa
09 14Spain
10 9Sweden
11 2Turkey
12 18USA
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Regulatory Info : Lead Market Dossiers- Under Development
Registration Country : India
Brand Name :
Dosage Form : Oral Solid Dosage Form
Dosage Strength : 50MG
Packaging :
Approval Date :
Application Number :
Regulatory Info : Lead Market Dossiers- Under Development
Registration Country : India
Regulatory Info :
Registration Country : Iran
Brand Name : Lotigna
Dosage Form : Hard Gelatin Capsule
Dosage Strength : 150MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Iran
Lee Fine Chem: Advancing Innovation and Quality in Intermediates, APIs, and Dosage Forms for Superior Pharmaceutical Solutions.
Regulatory Info :
Registration Country : India
Brand Name : Nilotinib
Dosage Form : Capsule
Dosage Strength : 150MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : India
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Regulatory Info : Lead Market Dossiers- Under Development
Registration Country : India
Brand Name :
Dosage Form : Oral Solid Dosage Form
Dosage Strength : 150MG
Packaging :
Approval Date :
Application Number :
Regulatory Info : Lead Market Dossiers- Under Development
Registration Country : India
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Regulatory Info : Lead Market Dossiers- Under Development
Registration Country : India
Brand Name :
Dosage Form : Oral Solid Dosage Form
Dosage Strength : 200MG
Packaging :
Approval Date :
Application Number :
Regulatory Info : Lead Market Dossiers- Under Development
Registration Country : India
Regulatory Info :
Registration Country : Iran
Brand Name : Lotigna
Dosage Form : Hard Gelatin Capsule
Dosage Strength : 200MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Iran
Lee Fine Chem: Advancing Innovation and Quality in Intermediates, APIs, and Dosage Forms for Superior Pharmaceutical Solutions.
Regulatory Info :
Registration Country : India
Brand Name : Nilotinib
Dosage Form : Capsule
Dosage Strength : 200MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : India
Regulatory Info : RX
Registration Country : USA
Brand Name : NILOTINIB HYDROCHLORIDE
Dosage Form : CAPSULE;ORAL
Dosage Strength : EQ 50MG BASE
Packaging :
Approval Date : 2024-01-05
Application Number : 203640
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : NILOTINIB HYDROCHLORIDE
Dosage Form : CAPSULE;ORAL
Dosage Strength : EQ 150MG BASE
Packaging :
Approval Date : 2024-01-05
Application Number : 203640
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : NILOTINIB HYDROCHLORIDE
Dosage Form : CAPSULE;ORAL
Dosage Strength : EQ 200MG BASE
Packaging :
Approval Date : 2024-01-05
Application Number : 203640
Regulatory Info : RX
Registration Country : USA
Regulatory Info :
Registration Country : USA
NILOTINIB HYDROCHLORIDE DIHYDRATE
Brand Name : NILOTINIB HYDROCHLORIDE DIHYDRATE
Dosage Form : CAPSULE
Dosage Strength : 200MG
Packaging :
Approval Date :
Application Number : 209651
Regulatory Info :
Registration Country : USA
Regulatory Info :
Registration Country : USA
NILOTINIB HYDROCHLORIDE DIHYDRATE
Brand Name : NILOTINIB HYDROCHLORIDE DIHYDRATE
Dosage Form : CAPSULE
Dosage Strength : 50MG
Packaging :
Approval Date :
Application Number : 209651
Regulatory Info :
Registration Country : USA
Regulatory Info :
Registration Country : USA
NILOTINIB HYDROCHLORIDE DIHYDRATE
Brand Name : NILOTINIB HYDROCHLORIDE DIHYDRATE
Dosage Form : CAPSULE
Dosage Strength : 150MG
Packaging :
Approval Date :
Application Number : 209651
Regulatory Info :
Registration Country : USA
Regulatory Info :
Registration Country : USA
Brand Name : NILOTINIB
Dosage Form : CAPSULE;ORAL
Dosage Strength : 150MG
Packaging :
Approval Date :
Application Number : 218544
Regulatory Info :
Registration Country : USA
Regulatory Info :
Registration Country : USA
Brand Name : NILOTINIB
Dosage Form : CAPSULE;ORAL
Dosage Strength : 200MG
Packaging :
Approval Date :
Application Number : 218544
Regulatory Info :
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : TASIGNA
Dosage Form : CAPSULE;ORAL
Dosage Strength : EQ 200MG BASE
Packaging :
Approval Date : 2007-10-29
Application Number : 22068
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : TASIGNA
Dosage Form : CAPSULE;ORAL
Dosage Strength : EQ 150MG BASE
Packaging :
Approval Date : 2010-06-17
Application Number : 22068
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : TASIGNA
Dosage Form : CAPSULE;ORAL
Dosage Strength : EQ 50MG BASE
Packaging :
Approval Date : 2018-03-22
Application Number : 22068
Regulatory Info : RX
Registration Country : USA
Regulatory Info :
Registration Country : USA
Brand Name : NILOTINIB
Dosage Form : CAPSULE
Dosage Strength : 150MG
Packaging :
Approval Date :
Application Number : 218532
Regulatory Info :
Registration Country : USA
Regulatory Info :
Registration Country : USA
Brand Name : NILOTINIB
Dosage Form : CAPSULE
Dosage Strength : 200MG
Packaging :
Approval Date :
Application Number : 218532
Regulatory Info :
Registration Country : USA